BIOAUTHORIZE HOLDINGS, INC. Financials

PERIOD ENDING30-Jun-0931-Mar-0931-Dec-0830-Sep-08Total Revenue1   -   -   -  Cost of Revenue -   -   -   -  Gross Profit1   -   -   -  Operating ExpensesResearch Development -   -   -  13  Selling General and Administrative21  18  12  190  Non Recurring -   -   -   -  Others8  8  8  8  Total Operating Expenses -   -   -   -  Operating Income or Loss(28)(25)(20)(211)Income from Continuing OperationsTotal Other Income/Expenses Net -   -  304  0  Earnings Before Interest And Taxes(28)(25)284  (211)Interest Expense -   -  0  0  Income Before Tax(28)(25)284  (211)Income Tax Expense -   -   -   -  Minority Interest -   -   -   -  Net Income From Continuing Ops(28)(25)284  (211)Non-recurring EventsDiscontinued Operations -   -   -   -  Extraordinary Items -   -   -   -  Effect Of Accounting Changes -   -   ...
Click here to read the whole Article (external link)

BIOAUTHORIZE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Management's Discussion and Analysis and the Risk Factors set forth in this Report on Form 10-Q may contain various "forward looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding future events or the future financial performance of the Company that involve risks and uncertainties. Certain statements included in this Form 10-Q, including, without limitation, statements related to anticipated cash flow sources and uses, and words including but not limited to "anticipates", "believes", "plans", "expects", "intends", "could", "might", "estimates", "future" and similar statements or expressions, identify forward looking statements. Forward-looking statements involve risks, uncertainties and other factors, which may cause our business, results of operations and financial position, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Any forward-looking statements herein are subject to certain risks and uncertainties in the Company's business, including but not limited to, the success or acceptance of our application offerings through Apple, Inc.'s App Store and Research in Motion Limited's ("RIM") App World, the completed development of our biometric technology, ongoing business strategies or prospects, difficulties of hiring or retaining key personnel, statements relating to future actions, trends in our businesses, prospective products, future performance or financial results and any changes in current accounting rules, all of which may be beyond the control of the Company. Additional, factors and risks that could affect our results and achievements and cause them to materially differ from those contained in the forward-looking statements include those ident...
Click here to read the whole Article (external link)

BIOAUTHORIZE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Management's Discussion and Analysis and the Risk Factors set forth in this Report on Form 10-Q may contain various "forward looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, regarding future events or the future financial performance of the Company that involve risks and uncertainties. Certain statements included in this Form 10-Q, including, without limitation, statements related to anticipated cash flow sources and uses, and words including but not limited to "anticipates", "believes", "plans", "expects", "intends", "could", "might", "estimates", "future" and similar statements or expressions, identify forward looking statements. Forward-looking statements involve risks, uncertainties and other factors, which may cause our business, results of operations and financial position, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Any forward-looking statements herein are subject to certain risks and uncertainties in the Company's business, including but not limited to, the success or acceptance of our application offerings through Apple, Inc.'s App Store and Research in Motion Limited's App World, the completed development of our biometric technology, ongoing business strategies or prospects, difficulties of hiring or retaining key personnel, statements relating to future actions, trends in our businesses, prospective products, future performance or financial results and any changes in current accounting rules, all of which may be beyond the control of the Company. Additional, factors and risks that could affect our results and achievements and cause them to materially differ from those contained in the forward-looking statements include those identified in the secti...
Click here to read the whole Article (external link)

BIOAUTHORIZE HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure

Show all filings for BIOAUTHORIZE HOLDINGS, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for BIOAUTHORIZE HOLDINGS, INC. 6-May-2009Entry into a Material Definitive Agreement, Regulation FD Disclosure Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information...
Click here to read the whole Article (external link)

BIOAUTHORIZE HOLDINGS, INC. Files SEC form 10-K, Annual Report

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OR PLAN OF OPERATION. The following is management's discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words "believes," "anticipates," "may," "will," "should," "expect," "intend," "estimate," "continue," and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements. The following discussion and analysis should be read in conjunction with our consolidated financial statements and the related notes thereto and other financial information contained elsewhere in this Form 10-K. Critical Accounting Policies We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Our manageme...
Click here to read the whole Article (external link)

BIOAUTHORIZE HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement

Item 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT Effective March 24, 2009, BioAuthorize, Inc., a wholly owned subsidiary of BioAuthorize Holdings, Inc., a Nevada corporation, activated an agreement with Apple, Inc. and Apple Subsidiaries ("Apple") with regard to the marketing, sales and end-user downloads of its application, yadaSay™ free-form English and Spanish languages translator, for the iPhone and the iTouch offered on the Apple App Store under the Utilities category (the "Agreement"). The contract expires February 13, 2010. The yadaSay™ application is offered at $0.99 per download and was launched on March 24, 2009. Apple receives a thirty percent (30%) commission on each download and collects and pays all sales tax on each sale of a download. BioAuthorize receives seventy percent (70%) of the sale of each download. The summary of the Agreement set forth above does not purport to be a complete statement of the terms of the Agreement. This summary is qualified in its entirety by reference to the full text of the Agreement. Item 7.01. REGULATION FD DISCLOSOURE On March 26, 2009, the Company issued a press release which is attached hereto as Exhibit 99.1 regarding the launch of its application, yadaSay™ free-form English and Spanish languages translator, for the Apple iPhone and the iTouch. The information in this Report on Form 8-K is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. This Report will not be deemed an admission as to the materiality of any information in the Report that is required to be disclosed solely by Regulation FD. The Company does not have, and expressly disclaims, any obligation to release publicly any updates or any changes in the Company's expectations or any change in events, conditions, or circumstances on which any forward-looking statement i...
Click here to read the whole Article (external link)

BIOAUTHORIZE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report

Show all filings for BIOAUTHORIZE HOLDINGS, INC. | Request a Trial to NEW EDGAR Online Pro Form 10-Q for BIOAUTHORIZE HOLDINGS, INC. 14-Nov-2008Quarterly Report Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not...
Click here to read the whole Article (external link)